Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001973141-25-000151
Filing Date
2025-03-14
Accepted
2025-03-14 16:10:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2981
  Complete submission text file 0001973141-25-000151.txt   4354
Mailing Address BAHNHOFSTRASSE 7 ZUG V8 6300
Business Address BAHNHOFSTRASSE 7 ZUG V8 6300 617-937-2423
Oculis Holding AG (Subject) CIK: 0001953530 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41636 | Film No.: 25740093
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O OCULIS HOLDING AG BAHNHOFSTRASSE 7 ZUG V6 CH-6300
Business Address
Sherif Riad (Reporting) CIK: 0002048639 (see all company filings)

Type: 144